Published on
December 5, 2024
- 22:52 GMT
World’s First Zero-Off-Target Base-edited NK Cell Therapy Receives IND Approval in Both China and the U.S.
SHANGHAI, CHINA, December 5, 2024 /EINPresswire.com/ -- Base Therapeutics has announced that its NK510 cell injection, the world’s first zero-off-target base-edited NK cell product, has received IND approvals from both the U.S. FDA and China’s NMPA for …
Distribution channels:
Agriculture, Farming & Forestry Industry, Healthcare & Pharmaceuticals Industry
...
